Association of the −262C/T polymorphism in the catalase gene promoter with carotid atherosclerosis in Slovenian patients with type 2 diabetes

• Authors: Mitja Letonja , Jovana Nikolajević-Starčević , Marija Šantl Letonja , Danijel Petrovič
• Languages of publication: EN

Abstracts

EN

Genetic variations of the antioxidant enzymes may influence the susceptibility to oxidative stress and consequently the development and progression of diabetic complications. The aim of the current study was to test the association between the −262C/T polymorphism in the catalase gene promoter and carotid atherosclerosis in Slovenian patients with type 2 diabetes. Two-hundred and eighty six diabetics and 150 healthy controls were enrolled in the study. Carotid atherosclerosis was quantified ultrasonographiocally by carotid intima-media thickness (CITM), plaque score and plaque type. Genotypes were determined using the real-time PCR. Fibrinogen concentration showed a borderline statistically significant difference due to catalase genotypes (p=0,05). No difference in clinical characteristics, CIMT, plaque stability or plaque score was observed. Logistic regression model adjusted for age, gender, smoking, BMI, lipid parameters and duration of hypertension and diabetes showed significant association of T allele and lower risk for higher plaque score (OR=0,25; p=0,025). No association with CIMT>1mm and unstable plaques was observed. T allele of −262C/T is associated with lower risk for higher plaque score but it did not affect clinical parameters, CIMT and plaque stability. Whether this polymorphism can be used as a genetic marker for advanced carotid atherosclerosis in diabetic patients needs to be evaluated in the future.

Keywords

EN

Diabetes mellitus type 2; Oxidative stress; Catalase polymorphism; Carotid atherosclerosis; Carotid intima-media thickness

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2011
• Volume: 6
• Issue: 4
• Pages: 463-469

Dates

published

1 - 8 - 2011

online

1 - 6 - 2011

Contributors

author

Mitja Letonja

• General hospital Ptuj, Potrčeva 25, Ptuj, 2250, Slovenia

author

Jovana Nikolajević-Starčević

• Institute of Histology and Embryology, Medical Faculty, University of Ljubljana, Ljubljana, 1105, Slovenia

author

Marija Šantl Letonja

• General hospital Rakičan, Ulica dr. Vrbnjaka 6, Murska Sobota, 9000, Slovenia

author

Danijel Petrovič

• Institute of Histology and Embryology, Medical Faculty, University of Ljubljana, Ljubljana, 1105, Slovenia

References

• [1] Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279:42351–42354 http://dx.doi.org/10.1074/jbc.R400019200[Crossref]
• [2] Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 2006; 212:167–178 http://dx.doi.org/10.1016/j.taap.2006.01.003[Crossref]
• [3] Chistiakov DA, Zotova EV, Savost’anov KV, Bursa TR, Galeev IV, Strokov IA et al. The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients. Diabetes Metab 2006; 32:63–68 http://dx.doi.org/10.1016/S1262-3636(07)70248-3
• [4] Li Y, Ambrosone CB, McCullough MJ, Ahn J, Stevens VL, Thun MJ et al. Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk. Carcinogenesis 2009; 30:777–784 http://dx.doi.org/10.1093/carcin/bgp053[Crossref][WoS]
• [5] Shull S, Heintz NH, Periasamy M, Manohar M, Janssen YM, Marsh JP et al. Differential regulation of antioxidant enzymes in response to oxidants. J Biol Chem 1991; 266:24398–23403 [PubMed]
• [6] Tate DJ, Miceli MV, Newsome DA. Phagocytosis and H2O2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1995; 36:1271–1279
• [7] Forsberg L, Lyrenäs L, de Faire U, Morgenstern R. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 2001; 30:500–505 http://dx.doi.org/10.1016/S0891-5849(00)00487-1[Crossref]
• [8] Nadif R, Mintz M, Jedlicka A, Bertrand JP, Kleeberger SR, Kauffmann F. Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli. Free Radic Res 2005; 39:1345–1350 http://dx.doi.org/10.1080/10715760500306711[Crossref]
• [9] Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL et al. Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol 2005; 162:943–952 http://dx.doi.org/10.1093/aje/kwi306[Crossref]
• [10] Mak JC, Leung HC, Ho SP, Ko FW, Cheung AH, Ip MS et al. Polymorphisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients. Clin Exp Allergy 2006; 36:440–447 http://dx.doi.org/10.1111/j.1365-2222.2006.02458.x[Crossref]
• [11] Jiang Z, Akey JM, Shi J, Xiong M, Wang Y, Shen Y et al. A polymorphism in the promoter region of catalase is associated with blood pressure levels. Hum Genet 2001; 109:95–98 http://dx.doi.org/10.1007/s004390100553[Crossref]
• [12] Zhou XF, Cui J, DeStefano AL, Chazaro I, Farrer LA, Manolis AJ et al. Polymorphisms in the promoter region of catalase gene and essential hypertension. Dis Markers 2005; 21:3–7 [PubMed][Crossref]
• [13] Casp CB, She JX, McCormack WT. Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res 2002; 15:62–66 http://dx.doi.org/10.1034/j.1600-0749.2002.00057.x[Crossref]
• [14] Chistiakov DA, Savost’anov KV, Turakulov RI, Titovich EV, Zilberman LI, Kuraeva TL et al. A new type 1 diabetes susceptibility locus containing the catalase gene chromosome 11p13) in a Russian population, Diabetes Metab Res Rev 2004; 20:219–224 http://dx.doi.org/10.1002/dmrr.442
• [15] Pask R, Cooper JD, Walker NM, Nutland S, Hutchings J, Dunger DB et al. No evidence for a major effect of two common polymorphisms of the catalase gene in type 1 diabetes susceptibility. Diabetes Metab Res Rev 2006; 22:356–360 http://dx.doi.org/10.1002/dmrr.628
• [16] Christiansen L, Petersen HC, Bathum L, Frederiksen H, McGue M, Christensen K. The catalase −262C/T promoter polymorphism and aging phenotypes. J Gerontol A Biol Sci Med Sci 2004; 59:B886–B889
• [17] dos Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I. The catalase −262C/T promoter polymorphism and diabetic complications in Caucasians with type 2 diabetes. Dis Markers 2006; 22:355–359
• [18] Góth L, Eaton JW. Hereditary catalase deficiencies and increased risk of diabetes. Lancet 2000; 356:1820–1821 http://dx.doi.org/10.1016/S0140-6736(00)03238-4[Crossref]
• [19] Goth L, Vitai M. The effects of hydrogen peroxide promoted by homocysteine and inherited catalase deficiency on human hypocatalasemic patients. Free Radic Biol Med 2003; 35:882–888 http://dx.doi.org/10.1016/S0891-5849(03)00435-0[Crossref]
• [20] World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization Department of Noncommunicable Disease Surveillance, 1999: 1–59
• [21] Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N et al. Mannheim carotid intima-media thickness consensus (2004–2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007; 23:75–80 http://dx.doi.org/10.1159/000097034[Crossref][WoS]
• [22] Lee EJ, Kim HJ, Bae JM, Kim JC, Han HJ, Park CS et al. Relevance of common carotid intimamedia thickness and carotid plaque as risk factors for ischemic stroke in patients with type 2 diabetes mellitus. AJNR Am J Neuroradiol 2007; 28:916–919.
• [23] Geroulakos G, Hobson RW, Nicolades A. Ultrasonographic carotid plaque morphology in predicting stroke risk. Br J Surg 1996; 83:582–587 http://dx.doi.org/10.1002/bjs.1800830505[Crossref]
• [24] Gray-Weale AC, Graham JC, Burnett JR, Byrne K, Lusby RJ. Carotid artery atheroma: comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology. J Cardiovasc surg 1998; 29:676–681
• [25] Montauban van Swijndregt AD, Elbers HR, Moll FL, de Letter J, Ackerstaff RG. Ultrasonographic characterization of carotid plaques. Ultrasound Med Biol 1998, 24:489–493 http://dx.doi.org/10.1016/S0301-5629(98)00005-2[Crossref]
• [26] Rahangdale S, Yeh SY, Malhotra A, Veves A. Therapeutic interventions and oxidative stress in diabetes. Front Biosci 2009; 14:192–209 http://dx.doi.org/10.2741/3240[WoS][Crossref]
• [27] Green D, Chan C, Kang J, Liu K, Schreiner P, Jenny NS et al. Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA study. J Thromb Haemost 2010; 8:489–495 http://dx.doi.org/10.1111/j.1538-7836.2009.03727.x[WoS][Crossref]
• [28] Antonini-Canterin F, La Carrubba S, Gullace G, Zito C, Di Bello V, Di Salvo G et al. Association between carotid atherosclerosis and metabolic syndrome: results from the ISMIR study. Angiology 2010; 61:443–448 http://dx.doi.org/10.1177/0003319709360523[Crossref]
• [29] MartÍnez-Vila E, Páramo JA, Beloqui O, Orbe J, Irimia P, Colina I et al. Independent association of fibrinogen with carotid intima-media thickness in asymptomatic subjects. Cerebrovasc Dis 2003; 16:356–362 http://dx.doi.org/10.1159/000072557[Crossref]
• [30] Pereira IA, Laurindo IM, Zimmermann AF, Werner Castro GR, Mello F, Borba EF. Single measurements of C-reactive protein and disease activity scores are not predictors of carotid atherosclerosis in rheumatoid arthritis patients. Acta Reumatol Port 2009; 34:58–64 [PubMed]
• [31] Retzinger GS. Adsorption and coagulability of fibrinogen on atheromatous lipid surfaces. Arterioscler Thromb Vasc Biol 1995; 15:786–792 [PubMed][Crossref]
• [32] Smith EB, Crosbie L. Fibrinogen and fibrin in atherogenesis. In: Ernst E, Koenig W, Lowe GDO, Meade TW, editors. Fibrinogen: A “New” Cardiovascular Risk Factor. Vienna, Austria: Blackwell-MZV; 1992. pp. 4–10
• [33] Duer MJ, Friscic T, Proudfoot D, Reid DG, Schoppet M, Shanahan CM et al. Mineral surface in calcified plaque is like that of bone. Arterioscler Thromb Vasc Biol 2008; 28:2030–2034 http://dx.doi.org/10.1161/ATVBAHA.108.172387[WoS][Crossref]
• [34] Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000; 49(2, Suppl 1):27–29 http://dx.doi.org/10.1016/S0026-0495(00)80082-7[Crossref]
• [35] D’souza A, Kurien BT, Rodgers R, Shenoi J, Kurono S, Matsumoto H et al. Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE. BMC Med Genet 2008; 9:62 http://dx.doi.org/10.1186/1471-2350-9-62[WoS][Crossref]

Identifiers

DOI

10.2478/s11536-011-0037-x